WOSERACT demographic data at baseline
| Variable | Entire sample (n = 167) | Active drug (n = 84) | Placebo (n = 83) | Mann–Whitney U test |
|---|---|---|---|---|
| Values are median (range) unless specified. | ||||
| ESR, erythrocyte sedimentation rate; HAQ, health assessment questionnaire; RE, rheumatoid factor. | ||||
| Age (years) | 56 | 55 | 56 | NS |
| (21 to 72) | (25 to 76) | (21 to 76) | ||
| Disease duration (months) | 12 | 12 | 12 | NS |
| (2 to 84) | (3 to 36) | (2 to 84) | ||
| RF positivity | 84% | 84% | 85% | |
| Per cent erosive | 51% | 51% | 52% | |
| Ratio M:F (n:n) | 59:108 | 29:55 | 30:53 | |
| Per cent smokers | 46% | 45% | 47% | |
| Swollen joints | 10 | 9 | 12 | NS |
| (0 to 30) | (0 to 30) | (0 to 30) | ||
| Early morning stiffness | 60 | 90 | 60 | NS |
| (0 to 720) | (5 to 720) | (0 to 720) | ||
| Pain score | 55 | 54 | 56 | NS |
| (0 to 100) | (3 to 100) | (0 to 100) | ||
| Articular index | 14 | 14 | 17 | NS |
| (2 to 56) | (3 to 47) | (2 to 56) | ||
| ESR (mm/h) | 38 | 34 | 40 | NS |
| (2 to 140) | (2 to 124) | (3 to 140) | ||
| C reactive protein (mg/l) | 21 | 17 | 25 | NS |
| (3 to 338) | (5 to 338) | (3 to 234) | ||
| HAQ | 1.75 | 1.75 | 1.625 | NS |
| (0 to 3.0) | (0 to 3.0) | (0 to 3.0) | ||